Role of NNMT and NM23A for diagnosis of RCC: Renal Cell Carcinoma
NNMT and NM23A emerge as promising non-invasive biomarkers for RCC, offering substantial diagnostic accuracy and reducing reliance on invasive procedures. Their integration into clinical workflows, supported by advanced machine learning methodologies, could transform RCC diagnostics. Further research with diverse populations is recommended to validate these findings and expand their clinical applicability.
Authors
- Arijit Saha (ORCID: https://orcid.org/0000-0003-1259-1496)
- Soumya Ranjan Behera
- Zaid Ahmad Khan
- Mamata Jena
- Suvendu Kumar Mohapatra (ORCID: https://orcid.org/0000-0002-6512-3736)
- Jyotsna Rani (ORCID: https://orcid.org/0000-0001-5227-1919)
- Samir Swain
- Pramod K. Mohanty
- Sabyasachi Panda
Institutions
- Sriram Chandra Bhanja Medical College Hospital (IN)
Publication Details
- Journal
- Urologia Journal
- Published
- 2025-09-28
- DOI
- https://doi.org/10.1177/03915603251376393
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00